- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 5/117 - Tétrapeptides le premier amino-acide étant hétérocyclique, p. ex. Pro, His, Trp
Détention brevets de la classe C07K 5/117
Brevets de cette classe: 238
Historique des publications depuis 10 ans
|
18
|
18
|
18
|
18
|
18
|
12
|
17
|
26
|
26
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The University of British Columbia | 1468 |
8 |
| Zedira GmbH | 36 |
8 |
| Limited Liability Company "lifemission" | 7 |
7 |
| Board of Regents, The University of Texas System | 5619 |
6 |
| The Arizona Board of Regents on Behalf of the University of Arizona | 2066 |
6 |
| Nissan Chemical Industries, Ltd. | 1757 |
5 |
| Palatin Technologies, Inc. | 75 |
5 |
| Bristol-myers Squibb Company | 4863 |
4 |
| CARA Therapeutics, Inc. | 72 |
4 |
| Eli Lilly and Company | 3720 |
4 |
| H. Lee Moffitt Cancer Center and Research Institute, Inc. | 896 |
4 |
| Hangzhou DAC Biotech Co., Ltd | 104 |
4 |
| Intezyne Technologies, Inc. | 57 |
4 |
| Onyx Therapeutics, Inc. | 71 |
4 |
| University of Cincinnati | 833 |
4 |
| Anygen Co., Ltd. | 36 |
3 |
| City University of Hong Kong | 181 |
3 |
| Cornell Research Foundation, Inc. | 311 |
3 |
| Genzyme Corporation | 1211 |
3 |
| Helix Biomedix Inc. | 33 |
3 |
| Autres propriétaires | 146 |